Zepbound vs Saxenda
Editorial comparison of Zepbound (tirzepatide) and Saxenda (liraglutide). Same drug class context, trial-anchored data, no marketing claims.
Side-by-side
| Dimension | Zepbound | Saxenda |
|---|---|---|
| Generic name | tirzepatide | liraglutide |
| Manufacturer | Eli Lilly | Novo Nordisk |
| FDA approved | 2023 | 2014 |
| Mechanism | Tirzepatide is a dual incretin agonist: it hits both the GLP-1 receptor (like semaglutide) and the GIP receptor (which semaglutide doesn't). | Single GLP-1 receptor agonist. Same mechanism family as semaglutide/Wegovy but shorter half-life (~13 hours) requiring daily dosing instead of weekly. |
| Dosing | Titrated 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg, every 4 weeks. Maintenance 5-15mg weekly depending on tolerability and target weight. | Titrated weekly: 0.6mg → 1.2mg → 1.8mg → 2.4mg → 3.0mg maintenance, all once daily. |
| Cost | List price ~$1,000-1,300/month. | List price ~$1,350/month. Cash-pay similar. Insurance coverage variable. Cheaper coupons through Novo Nordisk savings card programs. |
| Pivotal trial result | 20.9% mean body-weight reduction at 72 weeks (15 mg dose) | 8.4% mean body-weight reduction at 56 weeks (3.0 mg dose) |
Efficacy in the trials
20.9% mean body-weight reduction at 72 weeks (15 mg dose)
SURMOUNT-1 (NCT04184622) · vs 3.1% with placebo · n=2,539
8.4% mean body-weight reduction at 56 weeks (3.0 mg dose)
SCALE Obesity & Prediabetes (NCT01272219) · vs 2.8% with placebo · n=3,731
Trial averages describe study populations, not individuals. Response varies with the dose tolerated, adherence, and personal physiology; the two drugs were not necessarily tested head-to-head in the same trial.
The details
Dosing & cadence
Cost & access
Side effects
Which should you choose?
If maximizing average trial weight loss is the priority, Zepbound posted the higher pivotal-trial figure; Saxenda still produced clinically meaningful loss and some people tolerate it better. On cost and access, compare each drug's manufacturer direct-pay and insurance path — that often matters more month-to-month than the efficacy gap. Both carry class safety considerations (see each drug's boxed-warning and contraindications); a personal or family history of medullary thyroid carcinoma or MEN2 rules out the GLP-1 class. Bring this comparison to a prescriber, who will match the drug to your history and titrate the dose.
This is editorial framing, not a prescription. The right choice depends on your medical history, insurance, and a clinician's evaluation.
Full Zepbound review →
Dual GLP-1/GIP agonist for weight management. ~20% body weight loss in trials — strongest weight-loss drug currently available.
Full Saxenda review →
FDA-approved daily injectable liraglutide for chronic weight management. Older-generation GLP-1, daily dosing.
Deciding at the molecule level? Semaglutide vs Tirzepatide compares the two drug families behind every major GLP-1 brand.
Frequently asked
Is Zepbound or Saxenda more effective?+
In their pivotal trials, Zepbound reported 20.9% mean body-weight reduction at 72 weeks (15 mg dose), while Saxenda reported 8.4% mean body-weight reduction at 56 weeks (3.0 mg dose). Head-to-head results vary by patient profile, dose tolerated, and adherence — these trial numbers describe averages, not what every individual experiences.
How do Zepbound and Saxenda compare on cost?+
Zepbound: List price ~$1,000-1,300/month. Lilly's patient assistance program (LillyDirect Self-Pay) offers $399-549/month for self-pay patients depending on dose. Insurance coverage similar pattern to Wegovy. Saxenda: List price ~$1,350/month. Cash-pay similar. Insurance coverage variable. Cheaper coupons through Novo Nordisk savings card programs. Real out-of-pocket depends on insurance formulary tier, manufacturer savings programs, and whether a direct-pay channel is available.
Can I switch from Zepbound to Saxenda?+
Switching between brand-name treatments in the same drug class is common, but the conversion is not always 1:1. Discuss the switch with your prescriber — they'll usually re-titrate dosing rather than substitute equivalent strengths directly.
Are Zepbound and Saxenda the same drug?+
No. Zepbound (tirzepatide) and Saxenda (liraglutide) are distinct medications from Eli Lilly and Novo Nordisk respectively. They may share a drug class or mechanism but differ in active ingredient, dosing, and approved use.